Sorry, nothing in cart.

Puregraf 75 IU Injection
Price range: $20.00 through $99.00
| Active Ingredient (Generic Name) | Menotrophin (75IU) |
|---|---|
| Manufacturer | Gufic Biosciences Ltd. |
| Indication | Female infertility |
| Packaging | 1 Injection in 1 vial |
| Strength | 75iu |
| Delivery Time | 6 to 15 Days |
Puregraf 75 IU injection, containing Menotrophin, is a trusted therapy designed to treat female infertility by stimulating ovarian follicle development and ovulation. Ideal for women seeking effective fertility support.
| |||||||||||||||||||||||||
What is Puregraf 75 IU ?
Puregraf 75 IU is an injectable medication used to address female infertility issues. It contains the active ingredient Menotrophin, a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which play vital roles in the reproductive system. Manufactured by Gufic Biosciences Ltd., Puregraf 75 IU is targeted at women seeking assistance with ovulation and fertility challenges.
This medication is commonly prescribed by fertility specialists in the UK and Canada to stimulate ovarian follicle development in women who have difficulty conceiving naturally. With its precise hormonal composition, Puregraf 75 IU supports regulated ovarian stimulation to aid conception.
Uses of Puregraf 75 IU
- Treatment of female infertility due to anovulation or oligo-ovulation
- Stimulation of ovarian follicle development in women undergoing assisted reproductive technologies (ART) like IVF
- Induction of ovulation in patients with pituitary gland dysfunction
- Management of infertility where ovarian stimulation is required to improve chances of conception
How Puregraf 75 IU Works
Puregraf 75 IU works by supplying external follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which stimulate the growth and maturation of ovarian follicles. These hormones are naturally produced by the pituitary gland but may be deficient or ineffective in some women facing infertility. By providing a balanced dose of Menotrophin, the medication promotes follicular development, leading to ovulation.
Once mature follicles are formed, ovulation can occur, increasing the likelihood of fertilization and pregnancy. Under medical supervision, Puregraf 75 IU helps synchronize hormonal levels to mimic natural cycles and enhance fertility outcomes.
Benefits of Puregraf 75 IU
- Effective stimulation of ovarian follicle growth and maturation
- Assists in overcoming ovulatory infertility
- Supports women undergoing assisted reproductive techniques
- Provides a controlled and precise hormonal therapy option
- Manufactured under strict quality standards by Gufic Biosciences Ltd., ensuring safety and efficacy
Dosage and Administration
Puregraf 75 IU Injection is typically given under professional medical supervision, usually via intramuscular or subcutaneous injection. The dosage varies depending on the individual’s response and treatment plan prescribed by the healthcare provider. Treatment often starts with a low dose which can be adjusted as per follicular development monitored through ultrasound and hormonal assessments.
It is essential to adhere strictly to the prescribed schedule and not to self-administer without appropriate guidance. Regular monitoring during the treatment cycle helps optimize results and minimize risks.
Who Should Use Puregraf 75 IU ?
This medication is intended for women diagnosed with infertility caused by problems such as anovulation, oligo-ovulation, or pituitary gland disorders that affect normal hormone production. It is suitable for those undergoing fertility treatments like IVF or intrauterine insemination (IUI) where ovarian stimulation is necessary to increase chances of conception.
Who Should Avoid Puregraf 75 IU ?
Women who have hypersensitivity to Menotrophin or any other components of Puregraf 75 IU should avoid its use. It is not recommended for those with ovarian cysts unrelated to infertility, unexplained vaginal bleeding, or hormone-dependent cancers. Pregnant women or those with primary ovarian failure should not use this medication.
Side Effects
- Ovarian hyperstimulation syndrome (OHSS): Symptoms include abdominal pain, swelling, nausea, and vomiting. It requires immediate medical attention.
- Injection site reactions: Pain, redness, or swelling may occur at the site of injection.
- Headache and fatigue: Some patients may experience mild headaches or tiredness.
- Gynecological symptoms: Irregular bleeding, breast tenderness, or pelvic discomfort can happen.
- Allergic reactions: Rare but possible symptoms include rash, itching, or difficulty breathing.
Safety Advice
- Always use Puregraf 75 IU under strict medical supervision to monitor ovarian response.
- Do not self-administer; get proper training for injection techniques from healthcare professionals.
- Report any unusual symptoms, especially signs of OHSS or allergic reactions, promptly to your doctor.
- Inform your healthcare provider about existing health conditions or other medications being taken.
- Avoid using in pregnancy unless explicitly instructed by your physician.
- Follow the prescribed dosage schedule carefully to reduce risks of complications.
Drug Interactions
- Concurrent use with other fertility drugs may require dosage adjustments.
- Medications that influence hormone levels can affect how Puregraf 75 IU works.
- Inform your healthcare provider if taking corticosteroids or dopamine agonists.
- Careful monitoring is necessary when combining with other hormonal therapies.
Storage Instructions
Store Puregraf 75 IU injection in a refrigerator at temperatures between 2°C and 8°C (36°F and 46°F). Protect it from light and moisture. Do not freeze the product. Keep it out of reach of children and dispose of any expired or unused medication according to local regulations.
Where to buy Puregraf 75 IU in UK?
If you are looking to buy Puregraf 75 IU in the UK, it is best to consult a licensed pharmacy or a registered online supplier that complies with UK regulatory standards. Always ensure you purchase from reputable sources to guarantee the authenticity and quality of the medication. Physicians specializing in fertility treatments can also guide you on the best procurement options available locally.
Frequently Asked Questions (FAQ)
How long does it take for Puregraf 75 IU to work?
The time for Puregraf 75 IU to stimulate ovulation varies depending on the individual. Typically, follicle development can be observed within 7 to 10 days of starting treatment. Your doctor will monitor progress through ultrasounds and adjust dosage accordingly.
What should I do if Puregraf 75 IU does not work?
If the medication does not produce the desired response, consult your healthcare provider. They may reassess your treatment plan, perform additional tests, or consider alternative therapies to improve fertility outcomes.
What is the price of Puregraf 75 IU in the UK?
Prices may vary depending on the pharmacy or online supplier. It is recommended to check with authorized retailers or discuss cost options with your healthcare provider for accurate information.
Is Puregraf 75 IU safe for older adults?
Use in older women should be carefully evaluated by a fertility specialist, as ovarian response can vary with age. Safety and effectiveness depend on individual health status and should be monitored professionally.
What happens if I miss a dose of Puregraf 75 IU?
Missing a dose can disrupt the treatment cycle. Contact your doctor promptly for advice on when to resume medication to maintain effectiveness and safety.
Can side effects of Puregraf 75 IU be prevented?
While not all side effects can be avoided, following the prescribed dosage and attending regular medical check-ups helps minimize risks. Reporting any early symptoms to your healthcare provider is important for timely intervention.
When should I avoid using Puregraf 75 IU?
Avoid using this injection if you have known allergies to its components, unexplained vaginal bleeding, ovarian cysts unrelated to infertility, or hormone-sensitive cancers. Always disclose your medical history to your doctor before starting treatment.
Conclusion
Puregraf 75 IU is a valuable fertility treatment option for women experiencing ovulatory-related infertility. With its active ingredient Menotrophin, it effectively supports ovarian follicle development and enhances chances of conception when used under professional supervision. If you are considering fertility treatments in the UK or Canada, Puregraf 75 IU from Gufic Biosciences Ltd. offers a trusted solution with established safety and efficacy. Always consult a healthcare provider to determine if this medication suits your individual needs and to ensure proper management throughout your fertility journey.




Reviews
There are no reviews yet.